Clinical trial
Brain Natriuretic Peptide (BNP) to Preserve Renal Function in Hospitalized…
NCT00170183 · Mayo Clinic, Other · Completed
Key facts
| NCT number | NCT00170183 |
|---|---|
| Title | Brain Natriuretic Peptide (BNP) to Preserve Renal Function in Hospitalized Patients With Heart Failure |
| Official title | BNP as Adjuvant Therapy to Preserve Renal Function and Facilitate Diuresis in Hospitalized Patients With Heart Failure |
| Lead sponsor | Mayo Clinic, Other |
| Collaborators | Scios, Inc. Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Kidney Diseases, Congestive Heart Failure, Cardiomyopathy |
| Intervention type | Drug |
| Interventions | Nesiritide |
| Enrollment | 104 |
| Start date | Mar 1, 2003 |
| Primary completion | Jul 1, 2007 |
| Completion | Jul 1, 2008 |
| First posted | Sep 15, 2005 |
| Last update posted | Nov 16, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: